About Checkmate Pharmaceuticals
Checkmate Pharmaceuticals is a company based in Cambridge (United States) founded in 2015 was acquired by Regeneron Pharmaceuticals in April 2022.. Checkmate Pharmaceuticals has raised $175.08 million across 6 funding rounds from investors including Regeneron Pharmaceuticals, BrightEdge and Longitude Capital. The company has 16 employees as of December 31, 2018. Checkmate Pharmaceuticals operates in a competitive market with competitors including Moderna, Jazz Pharmaceuticals, BeiGene, Advanced Accelerator Applications and Incyte, among others.
- Headquarter Cambridge, United States
- Employees 16 as on 31 Dec, 2018
- Stage Public
-
Sectors
Healthcare
-
Phone
*********
-
Website
*********
-
Social
*********
- Legal Name Checkmate Pharmaceuticals, Inc.
-
Annual Revenue
-
Net Profit
-
EBITDA
-
Total Equity Funding
$175.08 M (USD)
in 6 rounds
-
Latest Funding Round
$85.08 M (USD), Series C
Jun 18, 2020
-
Investors
Regeneron Pharmaceuticals
& 10 more
-
Employee Count
16
as on Dec 31, 2018
-
Acquired by
Regeneron Pharmaceuticals
(Apr 19, 2022)
Unlock complete access to The Company Check
Get unrestricted viewing across everything we track — from companies and brands to investors, funding rounds, acquisitions, financials, and more.
- Unlimited viewing on all profiles Companies, investors, financials, funding, acquisitions & directors
- Full access to every database India & global coverage, advanced filters and rich profile details
- Always-on access from your team account Single premium plan for everything you see on the portal
Unlock access to complete
Unlock access to complete
Leadership Team
229 people
Software Development Team
223 people
Senior Team
81 people
Product Management Team
55 people
Legal and Compliance
46 people
Operations Team
43 people
Data Analysis and Operations Team
37 people
Human Resources and Administration
29 people
Unlock access to complete
Funding Insights of Checkmate Pharmaceuticals
Checkmate Pharmaceuticals has successfully raised a total of $175.08M across 6 strategic funding rounds. The most recent funding activity was a Series C round of $85.08 million completed in June 2020. This substantial capital infusion reflects strong investor confidence in the company's business model, growth potential, and market opportunities. The funding enables strategic expansion, product development, market penetration, and operational scaling to drive long-term value creation and competitive advantage.
- Total Funding Total Funding
- Total Rounds 6
- Last Round Series C — $85.1M
-
First Round
First Round
(16 Feb 2017)
- Investors Count 10
| Date | Amount | Transaction Name | Valuation | Lead Investors | Investors |
|---|---|---|---|---|---|
| Jun, 2020 | Amount | Series C - Checkmate Pharmaceuticals | Valuation | Longitude Capital , Novo Holdings | |
| Apr, 2020 | Amount | Debt – Conventional - Checkmate Pharmaceuticals | Valuation |
investors |
|
| Jan, 2020 | Amount | Series B - Checkmate Pharmaceuticals | Valuation |
investors |
|
| Date | Amount | Transaction Name | Valuation | Lead Investors | Investors |
|---|---|---|---|---|---|
| Jul, 2021 | Amount | Post-IPO - Grab | Valuation |
investors |
|
| Feb, 2021 | Amount | Post-IPO - Grab | Valuation |
investors |
|
| Jan, 2021 | Amount | Post-IPO - Grab | Valuation |
investors |
|
| Feb, 2021 | Amount | Post-IPO - Grab | Valuation |
investors |
Investors in Checkmate Pharmaceuticals
Checkmate Pharmaceuticals has secured backing from 11 investors, including venture fund and institutional investors. Prominent investors backing the company include Regeneron Pharmaceuticals, BrightEdge and Longitude Capital. This diverse investor base provides strategic capital, industry expertise, and valuable network connections that support the company's growth initiatives, market expansion, and long-term value creation.
| Investor | Description | Founded Year | Domain | Location |
|---|---|---|---|---|
|
Private equity firm focused on life science sector
|
Founded Year | Domain | Location | |
|
Private equity and venture capital fund focused on the healthcare sector
|
Founded Year | Domain | Location | |
|
Early-stage life science focused VC firm investing in geographies such as Europe and the US
|
Founded Year | Domain | Location |
| Investor | Description | Founded Year | Domain | Location |
|---|---|---|---|---|
|
Single family office of Amitabh Bachchan, founder of Amitabh Bachchan Corporation or AB CORP
|
Founded Year | Domain | Location | |
|
Startup ecosystems are ignited through strategic investments by Signite Partners.
|
Founded Year | Domain | Location | |
|
Venture capital is directed toward companies in multiple sectors.
|
Founded Year | Domain | Location | |
|
Venture capital is invested in cybersecurity, fintech, and AI startups.
|
Founded Year | Domain | Location |
Investments & Acquisitions by Checkmate Pharmaceuticals
| Company Name | Description | Domain | Location | Founded Year | Amount |
|---|---|---|---|---|---|
|
Bionic investment advisor platform
|
2016 | ||||
|
Fine Asian gourmet food is offered by an internet-first restaurant.
|
2016 | ||||
|
Physical e-commerce kiosks are deployed for rural purchases in Indonesia.
|
2014 | ||||
|
Fine Asian gourmet food is offered by an internet-first restaurant.
|
2016 |
Financial Statements - Checkmate Pharmaceuticals
| Date | Amount | Transaction Name | Valuation | Lead Investors | Investors |
|---|---|---|---|---|---|
| Jul, 2021 | Amount | Post-IPO - Grab | Valuation |
investors |
|
| Feb, 2021 | Amount | Post-IPO - Grab | Valuation |
investors |
|
| Jan, 2021 | Amount | Post-IPO - Grab | Valuation |
investors |
|
| Feb, 2021 | Amount | Post-IPO - Grab | Valuation |
investors |
Checkmate Pharmaceuticals Comparisons
Competitors of Checkmate Pharmaceuticals
Checkmate Pharmaceuticals operates in a dynamic and competitive business environment, facing competition from various established players and emerging companies in the market. The competitive landscape includes prominent companies such as Moderna, Jazz Pharmaceuticals, BeiGene, Advanced Accelerator Applications and Incyte, among others. This competitive environment drives innovation, market differentiation, and strategic positioning as companies strive to capture market share and deliver value to their customers. Understanding the competitive dynamics is crucial for assessing market positioning, identifying growth opportunities, and navigating the challenges inherent in a competitive marketplace.
| Company Name | Domain | Founded year | HQ Location | Description |
|---|---|---|---|---|
| domain | founded_year | HQ Location |
mRNA-based therapeutics for diseases including cancer and infections are developed.
|
|
| domain | founded_year | HQ Location |
Novel biopharmaceutical medicines are developed for unmet medical needs.
|
|
| domain | founded_year | HQ Location |
Targeted and immune-oncology drugs for cancer treatment are developed.
|
|
| domain | founded_year | HQ Location |
Radiopharmaceuticals for oncology diagnostics and therapies are developed and marketed.
|
|
| domain | founded_year | HQ Location |
Small molecules are developed for cancer and skin disease treatments.
|
|
| domain | founded_year | HQ Location |
Cancer therapies are developed using selective pathway inhibitors.
|
| Company Name | Domain | Founded year | HQ Location | Description |
|---|---|---|---|---|
| domain | founded_year | HQ Location |
Multiple services are booked via an app-based platform.
|
|
| domain | founded_year | HQ Location |
On-demand services are booked through an app-based platform.
|
|
| domain | founded_year | HQ Location |
App based platform offering on demand delivery and ride-hailing services
|
|
| domain | founded_year | HQ Location |
Operates an on-demand hyperlocal delivery app for food and groceries.
|
Latest news on Checkmate Pharmaceuticals
Frequently Asked Questions about Checkmate Pharmaceuticals
When was Checkmate Pharmaceuticals founded?
Checkmate Pharmaceuticals was founded in 2015 and raised its 1st funding round 2 years after it was founded.
Where is Checkmate Pharmaceuticals located?
Checkmate Pharmaceuticals is headquartered in Cambridge, United States. It is registered at Cambridge, Massachusetts, United States.
Is Checkmate Pharmaceuticals a funded company?
Checkmate Pharmaceuticals is a funded company, having raised a total of $175.08M across 6 funding rounds to date. The company's 1st funding round was a Series B of $16M, raised on Feb 16, 2017.
How many employees does Checkmate Pharmaceuticals have?
As of Dec 31, 2018, the latest employee count at Checkmate Pharmaceuticals is 16.
What does Checkmate Pharmaceuticals do?
Founded in 2015 and based in Cambridge, United States, Checkmate Pharmaceuticals operates in the biotechnology sector. Focus is placed on research and development of CpG DNA-based therapies to stimulate the innate immune system against tumors. This approach integrates Toll-like receptor 9 activation with checkpoint inhibitors. The lead candidate, CMP-001, a CpG-A oligonucleotide, is evaluated in combination with pembrolizumab for melanoma treatment in a Phase 1b trial.
Who are the top competitors of Checkmate Pharmaceuticals?
Checkmate Pharmaceuticals's top competitors include Moderna, Jazz Pharmaceuticals and Advanced Accelerator Applications.
Who are Checkmate Pharmaceuticals's investors?
Checkmate Pharmaceuticals has 11 investors. Key investors include Regeneron Pharmaceuticals, BrightEdge, Longitude Capital, Novo Holdings, and Medicxi.
Book a demo & talk to our team
Share a few details and we’ll reach out to schedule a session.